Prescribing Data in General Practice Demonstration (PDGPD) project - a cluster randomised controlled trial of a quality improvement intervention to achieve better prescribing for chronic heart failure and hypertension

[1]  J. Grimshaw,et al.  Printed educational materials: effects on professional practice and healthcare outcomes. , 2012, The Cochrane database of systematic reviews.

[2]  Jane M. Young,et al.  Audit and feedback: effects on professional practice and healthcare outcomes. , 2012, The Cochrane database of systematic reviews.

[3]  S. Brophy,et al.  Interventions for latent autoimmune diabetes (LADA) in adults. , 2011, The Cochrane database of systematic reviews.

[4]  T. Grodzicki,et al.  Competence of Polish primary-care doctors in the pharmacological treatment of hypertension. , 2010, Journal of Evaluation In Clinical Practice.

[5]  J. Ross,et al.  Self-Reported and Actual Beta-Blocker Prescribing for Heart Failure Patients: Physician Predictors , 2009, PloS one.

[6]  Fredric Wolf,et al.  Continuing education meetings and workshops: effects on professional practice and health care outcomes. , 2009, The Cochrane database of systematic reviews.

[7]  J. Christie,et al.  Planning a Cluster Randomized Controlled Trial: Methodological Issues , 2009, Nursing research.

[8]  Colin Simpson,et al.  Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003: A Population Study of 5.1 Million People , 2009, Circulation.

[9]  I. Kantola,et al.  Treatment of hypertension in Finnish general practice seems unsatisfactory despite evidence‐based guidelines , 2009, Blood pressure.

[10]  S. O'Riordan,et al.  Self‐reported prescribing for hypertension in general practice , 2008, Journal of clinical pharmacy and therapeutics.

[11]  P. Lindenauer,et al.  Cardiovascular risk tables Estimating risk is not the problem , using it to tailor treatment to individuals , 2008 .

[12]  M. Woodward,et al.  Polypharmacy management among Australian veterans: improving prescribing through the Australian Department of Veterans’ Affairs’ prescriber feedback programme , 2008, Internal medicine journal.

[13]  B. Wolffenbuttel,et al.  Cross-Sectional Versus Sequential Quality Indicators of Risk Factor Management in Patients with Type 2 Diabetes , 2008, Medical care.

[14]  C. van Weel,et al.  The influence of guideline revisions on the process and outcome of hypertension management in general practice: A descriptive study , 2008, The European journal of general practice.

[15]  J. Pirkis,et al.  Recruiting and retaining GPs and patients in intervention studies: the DEPS-GP project as a case study , 2007, BMC medical research methodology.

[16]  Henry Krum,et al.  chronic heart failure: new data from the , 2022 .

[17]  W. G. Stough,et al.  Underutilization of Evidence‐Based Therapies in Heart Failure: The Pharmacist's Role , 2007, Pharmacotherapy.

[18]  Claude Lenfant,et al.  Clinical practice and recent recommendations in hypertension management – reporting a gap in a global survey of 1259 primary care physicians in 17 countries , 2007, Current medical research and opinion.

[19]  Rob J Hyndman,et al.  Measurement of changes in antihypertensive drug utilisation following primary care educational interventions , 2007, Pharmacoepidemiology and drug safety.

[20]  Ulrike Dapp,et al.  Development, feasibility and performance of a health risk appraisal questionnaire for older persons , 2007, BMC medical research methodology.

[21]  F. Haaijer-Ruskamp,et al.  An educational programme for peer review groups to improve treatment of chronic heart failure and diabetes mellitus type 2 in general practice. , 2006, Journal of evaluation in clinical practice.

[22]  Theodore Speroff,et al.  Improving Blood Pressure Control through Provider Education, Provider Alerts, and Patient Education , 2006, Annals of Internal Medicine.

[23]  Vandana Sundaram,et al.  Quality Improvement Strategies for Hypertension Management: A Systematic Review , 2006, Medical care.

[24]  Andrew D Oxman,et al.  Rational Prescribing in Primary Care (RaPP): A Cluster Randomized Trial of a Tailored Intervention , 2006, PLoS medicine.

[25]  Aneel A. Advani,et al.  Improving adherence to guidelines for hypertension drug prescribing: cluster-randomized controlled trial of general versus patient-specific recommendations. , 2005, The American journal of managed care.

[26]  N. MacKinnon,et al.  Drug-therapy problems, inconsistencies and omissions identified during a medication reconciliation and seamless care service. , 2005, Healthcare Quarterly.

[27]  A. Bennett,et al.  Barriers to diagnosing and managing heart failure in primary care , 2005, The Medical journal of Australia.

[28]  Jeremy M Grimshaw,et al.  Improving management of hypertension in general practice: a randomised controlled trial of feedback derived from electronic patient data. , 2005, The British journal of general practice : the journal of the Royal College of General Practitioners.

[29]  S de Lusignan,et al.  Management of heart failure in primary care after implementation of the National Service Framework for Coronary Heart Disease: a cross-sectional study. , 2005, Public health.

[30]  K. Teo,et al.  Concordance, compliance and adherence in healthcare: closing gaps and improving outcomes. , 2005, Healthcare quarterly.

[31]  J. Holmes,et al.  Translating Research into Practice: Are Physicians Following Evidence-Based Guidelines in the Treatment of Hypertension? , 2004, Medical care research and review : MCRR.

[32]  S. Solomon,et al.  Effect of Candesartan on Cause-Specific Mortality in Heart Failure Patients: The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) Program , 2004, Circulation.

[33]  M. Maclure,et al.  Better Prescribing Project: a randomized controlled trial of the impact of case-based educational modules and personal prescribing feedback on prescribing for hypertension in primary care. , 2004, Family practice.

[34]  Colin Simpson,et al.  National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland , 2004, Heart.

[35]  M. Berry,et al.  Inhibition of Matrix Metalloproteinase Activity by TIMP-1 Gene Transfer Effectively Treats Ischemic Cardiomyopathy , 2004, Circulation.

[36]  G. Tofler,et al.  Barriers to diagnosing and managing heart failure in primary care , 2004, The Medical journal of Australia.

[37]  Ian Scott,et al.  Using clinical indicators in a quality improvement programme targeting cardiac care. , 2004, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[38]  Jonathan L. Blitstein,et al.  Design and analysis of group-randomized trials: a review of recent methodological developments. , 2004, American journal of public health.

[39]  G. Peterson,et al.  Undertreatment of congestive heart failure in an Australian setting , 2004, Journal of clinical pharmacy and therapeutics.

[40]  Richard Birtwhistle,et al.  Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. , 2003, BMC medical research methodology.

[41]  J. Shaw,et al.  Untreated hypertension among Australian adults: the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab) , 2003, The Medical journal of Australia.

[42]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[43]  W. Elliott,et al.  The Economic Impact of Hypertension , 2003, Journal of clinical hypertension.

[44]  A. Hungin,et al.  Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study , 2003, BMJ : British Medical Journal.

[45]  N. Freemantle,et al.  Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey , 2002, The Lancet.

[46]  M. Hotopf.  The pragmatic randomised controlled trial , 2002 .

[47]  G. Donnan,et al.  The Avoid Stroke as Soon as Possible (ASAP) general practice stroke audit , 2002, The Medical journal of Australia.

[48]  A Donner,et al.  Current and future challenges in the design and analysis of cluster randomization trials , 2001, Statistics in medicine.

[49]  K. Sweeney,et al.  Why general practitioners do not implement evidence: qualitative study , 2001, BMJ : British Medical Journal.

[50]  R. Cooper-DeHoff,et al.  How will INVEST and other hypertension trials change clinical practice? , 2001, Clinical cardiology.

[51]  Joanna E Cohen,et al.  Universities and tobacco money , 2001, BMJ : British Medical Journal.

[52]  H. Krum,et al.  PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension in Australia, 1994–1998 , 2001 .

[53]  A. Tonkin,et al.  Chronic heart failure in Australian general practice: The Cardiac Awareness Survey and Evaluation (CASE) Study , 2001, The Medical journal of Australia.

[54]  H. Moore,et al.  The design features and practicalities of conducting a pragmatic cluster randomized trial of obesity management in primary care. , 2001, Statistics in medicine.

[55]  M Eccles,et al.  Analysis of cluster randomized trials in primary care: a practical approach. , 2000, Family practice.

[56]  R Tomlins,et al.  Randomised controlled trial of effect of feedback on general practitioners' prescribing in Australia , 1999, BMJ.

[57]  C. Bradley,et al.  Factors which influence the decision whether or not to prescribe: the dilemma facing general practitioners. , 1992, The British journal of general practice : the journal of the Royal College of General Practitioners.

[58]  K. Abromeit.  Music Received , 2023, Notes.

[59]  G. Valpiani,et al.  Pharmacoeconomic Burden of Undertreating Hypertension , 2012, PharmacoEconomics.

[60]  Graeme J. Hankey,et al.  Guide to management of hypertension 2008 - Assessing and managing raised blood pressure in adults , 2008 .

[61]  M. Young,et al.  Health services research , 2008, Journal of General Internal Medicine.

[62]  Ralph B. D'Agostino,et al.  Wiley encyclopedia of clinical trials , 2008 .

[63]  J. Grimshaw,et al.  Printed educational materials: effects on professional practice and health care outcomes. , 2008, The Cochrane database of systematic reviews.

[64]  R. Borland,et al.  The Challenges of Recruiting and Retaining GPs in Research: Findings from a Smoking Cessation Project , 2007 .

[65]  J. Charles,et al.  General practice activity in Australia 2002-03 , 2003 .

[66]  C. Reid,et al.  Factors Influencing Family Physician Adherence to Hypertension Treatment Guideline Recommendations on the Initiation of Pharmacotherapy , 2003, American Journal of Cardiovascular Drugs.

[67]  P. Hjemdahl,et al.  Feedback on prescribing rate combined with problem-oriented pharmacotherapy education as a model to improve prescribing behaviour among general practitioners , 2001, European Journal of Clinical Pharmacology.

[68]  N Freemantle,et al.  Printed educational materials: effects on professional practice and health care outcomes. , 2000, The Cochrane database of systematic reviews.

[69]  J. Holmen,et al.  Implementing clinical guidelines in the treatment of hypertension in general practice. , 1998, Blood pressure.